 Vancouver, British Columbia--Newsfile Corp. - April 27, 2021 - Lexaria Bioscience Corp. CSE: LXX NASDAQ: LEXX - Chris Bunka, CEO and Chairman of Lexaria Bioscience, speaks about the Companys proprietary drug delivery technology, DehydraTECHTM.If you cannot view the video above, please visit: Bioscience is being featured on BNN Bloomber 